84P - Postoperative radiotherapy in resected stage III-N2 non-small cell lung cancer (NSCLC): can 3d-conformal radiotherapy improve the 5-year overall sur...

Date 28 March 2014
Event ELCC 2014
Session Lunch and poster display session
Topics Non-Small-Cell Lung Cancer, Locally Advanced
Surgery and/or Radiotherapy of Cancer
Presenter Charlotte Billiet
Citation Journal of Thoracic Oncology (2014) 9 (Supplement 9): S7-S52. 10.1097/JTO.0000000000000131
Authors C. Billiet1, Z. Gouw1, H. Decaluwé2, S. Peeters1, J. Vansteenkiste3, C. Dooms4, P. De Leyn2, D. De Ruysscher5
  • 1Radiaton Oncology, University Hospitals Leuven, 3000 - Leuven/BE
  • 2Thoracic Surgery And Leuven Lung Cancer Group, University Hospitals Leuven/ KU Leuven, 3000 - Leuven/BE
  • 3Respiratory Oncology Unit (pulmonology), University Hospitals Leuven - Campus Gasthuisberg, 3000 - Leuven/BE
  • 4Department Of Pulmonology And Leuven Lung Cancer Group, University Hospitals Leuven - Campus Gasthuisberg, 3000 - Leuven/BE
  • 5Radiation Oncology, University Hospitals Leuven - Campus Gasthuisberg, Leuven/BE

Abstract

To investigate the effect on 5-year OS of modern postoperative radiotherapy (PORT) in NSCLC patients with persistent N2 disease after induction chemotherapy.